Induced Pluripotent Stem Cells Generated Without Viral Integration
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Pluripotent stem cells have been generated from mouse and human somatic cells by viral expression of the transcription factors Oct4, Sox2, Klf4, and c-Myc. A major limitation of this technology is the use of potentially harmful genome-integrating viruses. We generated mouse induced pluripotent stem (iPS) cells from fibroblasts and liver cells by using nonintegrating adenoviruses transiently expressing Oct4, Sox2, Klf4, and c-Myc. These adenoviral iPS (adeno-iPS) cells show DNA demethylation characteristic of reprogrammed cells, express endogenous pluripotency genes, form teratomas, and contribute to multiple tissues, including the germ line, in chimeric mice. Our results provide strong evidence that insertional mutagenesis is not required for in vitro reprogramming. Adenoviral reprogramming may provide an improved method for generating and studying patient-specific stem cells and for comparing embryonic stem cells and iPS cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Adenovirus and Sendai virus-mediated vector delivery provide alternative non-integrative methods for iPSC reprogramming [24,25,26,27,28].”
From Overcoming the Variability of iPSCs in the Manufacturing of Cell-Based Therapies (2023) · cites this paper as [24]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310
Generation of germline-competent induced pluripotent stem cells
Okita, K., Ichisaka, T., & Yamanaka, S. (2007) · Nature · doi:10.1038/nature05934 · Cited by 4,299
In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state
Wernig, M., Meissner, A., Foreman, R., Brambrink, T., Ku, M., Hochedlinger, K., Bernstein, B. E., & Jaenisch, R. (2007) · Nature · doi:10.1038/nature05944 · Cited by 2,676
Self-citationReprogramming of human somatic cells to pluripotency with defined factors
Park, I.-H., Zhao, R., West, J. A., Yabuuchi, A., Huo, H., Ince, T. A., Lerou, P. H., Lensch, M. W., & Daley, G. Q. (2008) · Nature · doi:10.1038/nature06534 · Cited by 2,436
Maherali, N., Sridharan, R., Xie, W., Utikal, J., Eminli, S., Arnold, K., Stadtfeld, M., Yachechko, R., Tchieu, J., Jaenisch, R., et al. (2007) · Cell stem cell · doi:10.1016/j.stem.2007.05.014 · Cited by 1,725
Self-citationHuangfu, D., Maehr, R., Guo, W., Eijkelenboom, A., Snitow, M., Chen, A. E., & Melton, D. A. (2008) · Nature Biotechnology · doi:10.1038/nbt1418 · Cited by 1,606
Dissecting direct reprogramming through integrative genomic analysis
Mikkelsen, T. S., Hanna, J., Zhang, X., Ku, M., Wernig, M., Schorderet, P., Bernstein, B. E., Jaenisch, R., Lander, E. S., & Meissner, A. (2008) · Nature · doi:10.1038/nature07056 · Cited by 1,480
Wernig, M., Zhao, J.-P., Pruszak, J., Hedlund, E., Fu, D., Soldner, F., Broccoli, V., Constantine-Paton, M., Isacson, O., & Jaenisch, R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801677105 · Cited by 1,216
Research works printed but not linked: 1
- S. Eminli J. Utikal K. Arnold R. Jaenisch K. Hochedlinger Stem Cells published online 17June2008 in press.
Cited by
Items 201–300 of 1,002
Induced pluripotent stem cells and reprogramming: seeing the science through the hype
Belmonte, J. C. I., Ellis, J., Hochedlinger, K., & Yamanaka, S. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2700 · Cited by 108
Self-citationAbbasalizadeh, S., & Baharvand, H. (2013) · Biotechnology Advances · doi:10.1016/j.biotechadv.2013.08.009 · Cited by 108
Emerging use of stem cells in regenerative medicine
Teo, A. K. K., & Vallier, L. (2010) · Biochemical Journal · doi:10.1042/bj20100102 · Cited by 108
Generation of Integration-free and Region-Specific Neural Progenitors from Primate Fibroblasts
Lü, J., Liu, H., Huang, C. T.-L., Chen, H., Du, Z., Liu, Y., Sherafat, M. A., & Zhang, S. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.04.004 · Cited by 108
Freund, C. M. A. H., & Mummery, C. L. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22164 · Cited by 108
Mechanism of Induction: Induced Pluripotent Stem Cells (iPSCs).
Singh, V. K., Kumar, N., Kalsan, M., Saini, A., & Chandra, R. (2015) · PubMed · Cited by 107
Small molecules facilitate rapid and synchronous iPSC generation
Bar-Nur, O., Brumbaugh, J., Verheul, C., Apostolou, E., Pruteanu-Malinici, I., Walsh, R. M., Ramaswamy, S., & Hochedlinger, K. (2014) · Nature Methods · doi:10.1038/nmeth.3142 · Cited by 107
Self-citationInduced pluripotent stem cells and senescence: learning the biology to improve the technology
Banito, A., & Gil, J. (2010) · EMBO reports · doi:10.1038/embor.2010.47 · Cited by 107
Ye, D., Wang, G., Liu, Y., Huang, W., Wu, M., Zhu, S., Jia, W., Deng, A., Liu, H., & Kang, J. (2012) · Stem Cells · doi:10.1002/stem.1149 · Cited by 107
iPS-Cell Technology and the Problem of Genetic Instability—Can It Ever Be Safe for Clinical Use?
Attwood, S. W., & Edel, M. J. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8030288 · Cited by 107
Fluri, D. A., Tonge, P. D., Song, H., Baptista, R. P., Shakiba, N., Shukla, S., Clarke, G., Nagy, A., & Zandstra, P. W. (2012) · Nature Methods · doi:10.1038/nmeth.1939 · Cited by 106
Nandan, M. O., & Yang, V. W. (2009) · PubMed · doi:10.14670/hh-24.1343 · Cited by 106
Induced pluripotent stem cells and personalized medicine: current progress and future perspectives
Chun, Y. S., Byun, K., & Lee, B. (2011) · Anatomy & Cell Biology · doi:10.5115/acb.2011.44.4.245 · Cited by 106
Lee, T.-H., Song, S.-H., Kim, K. L., Yi, J.-Y., Shin, G.-H., Kim, J. Y., Kim, J., Han, Y.-M., Lee, S. H., Lee, S.-H., et al. (2010) · Circulation Research · doi:10.1161/circresaha.109.207902 · Cited by 106
Matsa, E., Ahrens, J. H., & Wu, J. C. (2016) · Physiological Reviews · doi:10.1152/physrev.00036.2015 · Cited by 105
All Roads Lead to Induced Pluripotent Stem Cells: The Technologies of iPSC Generation
Hu, K. (2014) · Stem Cells and Development · doi:10.1089/scd.2013.0620 · Cited by 105
Functional Cardiac Tissue Engineering
Liau, B., Zhang, D., & Bursac, N. (2012) · Regenerative Medicine · doi:10.2217/rme.11.122 · Cited by 105
Su, R. J., Baylink, D. J., Neises, A., Kiroyan, J. B., Meng, X., Payne, K. J., Tschudy-Seney, B., Duan, Y., Appleby, N. C., Kearns‐Jonker, M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064496 · Cited by 104
Reprogramming of Human Fibroblasts to Induced Pluripotent Stem Cells under Xeno-free Conditions
Rodríguez-Pizà, I., Richaud-Patin, Y., Vassena, R., González, F., Barrero, M. J., Veiga, A., Raya, A., & Belmonte, J. C. I. (2010) · Stem Cells · doi:10.1002/stem.248 · Cited by 103
Pakzad, M., Totonchi, M., Taei, A., Seifinejad, A., Hassani, S., & Baharvand, H. (2009) · Stem Cell Reviews and Reports · doi:10.1007/s12015-009-9103-z · Cited by 102
Grabundžija, I., Wang, J., Sebe, A., Erdei, Z., Kajdi, R., Devaraj, A., Steinemann, D., Szuhai, K., Stein, U., Cantz, T., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1305 · Cited by 102
Godfrey, K. J., Mathew, B., Bulman, J. C., Shah, O., Clément, S., & Gallicano, G. I. (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03433.x · Cited by 102
Human pluripotent stem cells in drug discovery and predictive toxicology
Laustriat, D., Gide, J., & Peschanski, M. (2010) · Biochemical Society Transactions · doi:10.1042/bst0381051 · Cited by 101
Gunaseeli, I., Doss, M., Antzelevitch, C., Hescheler, J., & Sachinidis, A. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710790514480 · Cited by 101
Drozd, A. M., Walczak, M. P., Piaskowski, S., Stoczyńska-Fidelus, E., Rieske, P., & Grzela, D. P. (2015) · Stem Cell Research & Therapy · doi:10.1186/s13287-015-0112-3 · Cited by 101
Cardiac repair and regeneration: the Rubik’s cube of cell therapy for heart disease
Boudoulas, K. D., & Hatzopoulos, A. K. (2009) · Disease Models & Mechanisms · doi:10.1242/dmm.000240 · Cited by 101
Generation of Pig iPS Cells: A Model for Cell Therapy
Montserrat, N., Garreta, E., Batlle‐Morera, L., Häfner, S. J., Rodrigues, A. M. C., Gonzãlez, F., & Belmonte, J. C. I. (2010) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-010-9233-3 · Cited by 101
Development of a Biological Ventricular Assist Device: Preliminary Data From a Small Animal Model
Yildirim, Y., Naito, H., Didié, M., Karikkineth, B. C., Biermann, D., Eschenhagen, T., & Zimmermann, W.-H. (2007) · Circulation · doi:10.1161/circulationaha.106.679688 · Cited by 100
“Darüber hinaus gelang es ebenfalls pluripotente Stammzellen durch Einschleusen der rekombinierten Proteine herzustellen [36].”
BackgroundPI3K/AKT Signaling Pathway Is Essential for Survival of Induced Pluripotent Stem Cells
Hossini, A. M., Quast, S.-A., Plötz, M., Grauel, M. K., Exner, T., Küchler, J., Stachelscheid, H., Eberle, J., Rabien, A., Makrantonaki, E., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0154770 · Cited by 100
Lenman, A., Liaci, A. M., Liu, Y., Årdahl, C., Rajan, A., Nilsson, E., Bradford, W. S., Kaeshammer, L., Jones, M. S., Frängsmyr, L., et al. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1004657 · Cited by 100
iPS Programmed Without c-MYC Yield Proficient Cardiogenesis for Functional Heart Chimerism
Martinez-Fernandez, A., Nelson, T. J., Yamada, S., Reyes, S., Alekseev, A. E., Perez-Terzic, C., Ikeda, Y., & Terzic, A. (2009) · Circulation Research · doi:10.1161/circresaha.109.203109 · Cited by 99
Generation of induced pluripotent stem cells from neural stem cells
Kim, J. B., Zaehres, H., Araúzo-Bravo, M. J., & Schöler, H. R. (2009) · Nature Protocols · doi:10.1038/nprot.2009.173 · Cited by 99
Stem Cell Platforms for Regenerative Medicine
Nelson, T. J., Behfar, A., Yamada, S., Martinez‐Fernandez, A., & Terzic, A. (2009) · Clinical and Translational Science · doi:10.1111/j.1752-8062.2009.00096.x · Cited by 99
Rosselló, R. A., Chen, C., Dai, R., Howard, J. T., Hochgeschwender, U., & Jarvis, E. D. (2013) · eLife · doi:10.7554/elife.00036 · Cited by 99
Yu, W. Y., Sheridan, C., Grierson, I., Mason, S. L., Kearns, V., Lo, A., & Wong, D. (2011) · BioMed Research International · doi:10.1155/2011/412743 · Cited by 99
Diversity among POU transcription factors in chromatin recognition and cell fate reprogramming
Malik, V., Zimmer, D., & Jauch, R. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2748-5 · Cited by 98
Pfannkuche, K., Liang, H., Hannes, T., Xi, J., Fatima, A., Nguemo, F., Matzkies, M., Wernig, M., Jaenisch, R., Pillekamp, F., et al. (2009) · Cellular Physiology and Biochemistry · doi:10.1159/000227815 · Cited by 98
Meng, X., Neises, A., Su, R.-J., Payne, K. J., Ritter, L., Gridley, D. S., Wang, J., Sheng, M., William Lau, K.-H., Baylink, D. J., et al. (2012) · Molecular Therapy · doi:10.1038/mt.2011.258 · Cited by 98
Messenger RNA Delivery for Tissue Engineering and Regenerative Medicine Applications
Patel, S., Athirasala, A., Menezes, P. P., Ashwanikumar, N., Zou, T., Sahay, G., & Bertassoni, L. E. (2019) · Tissue Engineering Part A · doi:10.1089/ten.tea.2017.0444 · Cited by 98
Filling the Gap: Neural Stem Cells as A Promising Therapy for Spinal Cord Injury
Pereira, I. M., Marote, A., Salgado, A. J., & Silva, N. A. (2019) · Pharmaceuticals · doi:10.3390/ph12020065 · Cited by 98
Pluripotent human stem cells for the treatment of retinal disease
Rowland, T. J., Buchholz, D. E., & Clegg, D. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22814 · Cited by 97
The Use of Stem Cell-Derived Organoids in Disease Modeling: An Update
Azar, J., Bahmad, H. F., Daher, D., Moubarak, M. M., Hadadeh, O., Monzer, A., Al Bitar, S., Jamal, M., Al-Sayegh, M., & Abou-Kheir, W. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147667 · Cited by 96
Epigenetic regulatory mechanisms during preimplantation development
Corry, G. N., Tanasijevic, B., Barry, E., Krueger, W. H., & Rasmussen, T. P. (2009) · Birth Defects Research Part C Embryo Today Reviews · doi:10.1002/bdrc.20165 · Cited by 96
iPS cell technology in regenerative medicine
Lengner, C. J. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05213.x · Cited by 95
Medvedev, S. P., Grigor’eva, E. V., Shevchenko, A. I., Malakhova, A. A., Dementyeva, E. V., Shilov, A. A., Pokushalov, E. A., Zaidman, A. M., Aleksandrova, M. A., Plotnikov, E. Y., et al. (2010) · Stem Cells and Development · doi:10.1089/scd.2010.0249 · Cited by 95
Carpenter, L., Carr, C., Yang, C. T., Stuckey, D. J., Clarke, K., & Watt, S. M. (2012) · Stem Cells and Development · doi:10.1089/scd.2011.0075 · Cited by 94
Concise Review: A Chemical Approach to Control Cell Fate and Function
Li, W., Jiang, K., & Ding, S. (2012) · STEM CELLS · doi:10.1002/stem.768 · Cited by 93
Three-dimensional cardiac tissue fabrication based on cell sheet technology
Masuda, S., & Shimizu, T. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.05.002 · Cited by 93
Shao, L., Feng, W., Sun, Y., Bai, H., Liu, J., Currie, C., Kim, J., Gama, R., Wang, Z., Qian, Z., et al. (2009) · Cell Research · doi:10.1038/cr.2009.20 · Cited by 92
The challenge of immunogenicity in the quest for induced pluripotency
Fairchild, P. J. (2010) · Nature reviews. Immunology · doi:10.1038/nri2878 · Cited by 92
Two decades of embryonic stem cells: a historical overview
Eguizabal, C., Aran, B., Chuva de Sousa Lopes, S. M., Geens, M., Heindryckx, B., Panula, S., Popovic, M., Vassena, R., & Veiga, A. (2019) · Human Reproduction Open · doi:10.1093/hropen/hoy024 · Cited by 91
Kane, N. M., Xiao, Q., Baker, A. H., Luo, Z., Xu, Q., & Emanueli, C. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.10.004 · Cited by 90
Tiemann, U., Sgodda, M., Warlich, E., Ballmaier, M., Schöler, H. R., Schambach, A., & Cantz, T. (2011) · Cytometry Part A · doi:10.1002/cyto.a.21072 · Cited by 90
The use of small molecules in somatic-cell reprogramming
Alexander Joel Federation, Bradner, J. E., & Meissner, A. (2013) · Trends in Cell Biology · doi:10.1016/j.tcb.2013.09.011 · Cited by 90
Talluri, T. R., Kumar, D., Glage, S., Garrels, W., Ivics, Z., Debowski, K., Behr, R., Niemann, H., & Kues, W. A. (2015) · Cellular Reprogramming · doi:10.1089/cell.2014.0080 · Cited by 90
The role of purinergic receptors in stem cell differentiation
Kaebisch, C., Schipper, D., Babczyk, P., & Tobiasch, E. (2014) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2014.11.003 · Cited by 89
Selvaraj, V., Plane, J. M., Williams, A. J., & Deng, W. (2010) · Trends in biotechnology · doi:10.1016/j.tibtech.2010.01.002 · Cited by 88
Cancer stem cells and hepatocellular carcinoma
Yao, Z., & Mishra, L. (2009) · Cancer Biology & Therapy · doi:10.4161/cbt.8.18.9843 · Cited by 88
Huang, B., Li, T., Alonso‐González, L., Gorre, R., Keatley, S. K., Green, A., Turner, P., Kallingappa, P. K., Verma, V., & Oback, B. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024501 · Cited by 88
mRNA-Based Genetic Reprogramming
Warren, L., & Lin, C. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2018.12.009 · Cited by 87
Stem Cell Models for Drug Discovery and Toxicology Studies
Liu, W., Deng, Y., Liu, Y., Gong, W., & Deng, W. (2013) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.21470 · Cited by 87
Anti-Aging Strategies Based on Cellular Reprogramming
Ocampo, A., Reddy, P., & Belmonte, J. C. I. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.06.005 · Cited by 87
Reprogramming with Small Molecules instead of Exogenous Transcription Factors
Lin, T., & Wu, S. (2015) · Stem Cells International · doi:10.1155/2015/794632 · Cited by 87
Kues, W. A., Herrmann, D., Barg‐Kues, B., Haridoss, S., Nowak‐Imialek, M., Buchholz, T. A., Streeck, M., Grebe, A., Grabundžija, I., Merkert, S., et al. (2012) · Stem Cells and Development · doi:10.1089/scd.2012.0382 · Cited by 87
Tang, Z.-H., Chen, J.-R., Zheng, J., Shi, H., Ding, J., Qian, X., Zhang, C., Chen, J., Wang, C.-C., Li, L., et al. (2016) · Stem Cells Translational Medicine · doi:10.5966/sctm.2015-0252 · Cited by 87
Shahjalal, H. M., Shiraki, N., Sakano, D., Kikawa, K., Ogaki, S., Baba, H., Kume, K., & Kume, S. (2014) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mju029 · Cited by 87
Stem cell-based strategies and challenges for production of cultivated meat
Jara, T., Park, K., Vahmani, P., Eenennaam, A. L. V., Smith, L., & Denicol, A. C. (2023) · Nature Food · doi:10.1038/s43016-023-00857-z · Cited by 86
DNA hypermethylation accompanied by transcriptional repression in follicular lymphoma
Bennett, L. B., Schnabel, J. L., Kelchen, J. M., Taylor, K. H., Guo, J., Arthur, G. L., Papageorgio, C., Shi, H., & Caldwell, C. W. (2009) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20687 · Cited by 85
Ye, L., Muench, M. O., Fusaki, N., Beyer, A. I., Wang, J., Qi, Z., Yu, J., & Kan, Y. W. (2013) · Stem Cells Translational Medicine · doi:10.5966/sctm.2013-0006 · Cited by 85
Cardiomyocyte differentiation of pluripotent stem cells and their use as cardiac disease models
Dambrot, C., Passier, R. C., Atsma, D. E., & Mummery, C. L. (2011) · Biochemical Journal · doi:10.1042/bj20101707 · Cited by 85
Reprogramming with defined factors: from induced pluripotency to induced transdifferentiation
Masip, M., Veiga, A., Belmonte, J. C. I., & Simón, C. (2010) · Molecular Human Reproduction · doi:10.1093/molehr/gaq059 · Cited by 85
Clinical potentials of human pluripotent stem cells
Mora, C., Serzanti, M., Consiglio, A., Memo, M., & Dell’Era, P. (2017) · Cell Biology and Toxicology · doi:10.1007/s10565-017-9384-y · Cited by 85
Age Is Relative—Impact of Donor Age on Induced Pluripotent Stem Cell-Derived Cell Functionality
Strässler, E. T., Aalto‐Setälä, K., Kiamehr, M., Landmesser, U., & Kränkel, N. (2018) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2018.00004 · Cited by 84
Human pluripotent stem cell–derived models and drug screening in CNS precision medicine
Silva, M. C., & Haggarty, S. J. (2020) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14012 · Cited by 83
Yang, J., Li, S., He, X.-B., Cheng, C., & Le, W. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0106-3 · Cited by 83
Fibroblast-Derived Induced Pluripotent Stem Cells Show No Common Retroviral Vector Insertions
Varas, F., Stadtfeld, M., de Andrés-Aguayo, L., Maherali, N., Tullio, A. D., Pantano, L., Notredame, C., Hochedlinger, K., & Graf, T. (2009) · Stem Cells · doi:10.1634/stemcells.2008-0696 · Cited by 82
Self-citationGieni, R. S., & Hendzel, M. J. (2009) · Biochemistry and Cell Biology · doi:10.1139/o09-057 · Cited by 82
Montserrat, N., Garreta, E., Gonzãlez, F., Gutiérrez, J., Eguizábal, C., Ramos, V., Borrós, S., & Belmonte, J. C. I. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.168013 · Cited by 82
Using human induced pluripotent stem cells to treat retinal disease
Borooah, S., Phillips, M. J., Bilican, B., Wright, A. F., Wilmut, I., Chandran, S., Gamm, D. M., & Dhillon, B. (2013) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2013.09.002 · Cited by 81
Can cellular models revolutionize drug discovery in Parkinson's disease?
Schüle, B., Pera, R. A. R., & Langston, J. W. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.08.014 · Cited by 81
Genetic engineering of stem cells for enhanced therapy
Nowakowski, A., Andrzejewska, A., Janowski, M., Walczak, P., & Łukomska, B. (2013) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2013-1918 · Cited by 81
Papapetrou, E. P., & Sadelain, M. (2011) · Nature Protocols · doi:10.1038/nprot.2011.374 · Cited by 80
Size matters: versatile use of PiggyBac transposons as a genetic manipulation tool
Kim, A., & Pyykkö, I. V. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-0832-3 · Cited by 80
Induced pluripotent stem cells: A new era for hepatology
Asgari, S., Pournasr, B., Salekdeh, G. H., Ghodsizadeh, A., Ott, M., & Baharvand, H. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.05.009 · Cited by 80
Lu, H., Chai, C., Lim, T. C., Leong, M. F., Lim, J. K., Gao, S., Lim, K., & Wan, A. C. A. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.12.050 · Cited by 80
Pasha, Z., Haider, H. K., & Ashraf, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023667 · Cited by 80
Induced pluripotent stem cell (iPSCs) and their application in immunotherapy
Jiang, Z., Han, Y., & Cao, X. (2013) · Cellular and Molecular Immunology · doi:10.1038/cmi.2013.62 · Cited by 79
Kramer, A. S., Harvey, A. R., Plant, G. W., & Hodgetts, S. I. (2013) · Cell Transplantation · doi:10.3727/096368912x655208 · Cited by 79
Stem cell therapies for treating osteoarthritis: Prescient or premature?
Whitworth, D. J., & Banks, T. A. (2014) · The Veterinary Journal · doi:10.1016/j.tvjl.2014.09.024 · Cited by 79
Wound healing and regenerative strategies
Nauta, A., Gurtner, G., & Longaker, M. (2011) · Oral Diseases · doi:10.1111/j.1601-0825.2011.01787.x · Cited by 78
Zwi-Dantsis, L., Huber, I., Habib, M., Winterstern, A., Gepstein, A., Arbel, G., & Gepstein, L. (2013) · European Heart Journal · doi:10.1093/eurheartj/ehs096 · Cited by 78
Chang, Y.-C., Chang, W.-C., Hung, K.-H., Yang, D.-M., Cheng, Y.-H., Liao, Y.-W., Woung, L.-C., Tsai, C.-Y., Hsu, C.-C., Lin, T.-C., et al. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00191 · Cited by 78
Generation of pluripotent stem cells without the use of genetic material
Higuchi, A., Ling, Q., Kumar, S. S., Munusamy, M. A., Alarfaj, A. A., Chang, Y., Kao, S.-H., Lin, K.-C., Wang, H.-C., & Umezawa, A. (2014) · Laboratory Investigation · doi:10.1038/labinvest.2014.132 · Cited by 78
Nuclear receptor regulation of stemness and stem cell differentiation
Jeong, Y., & Mangelsdorf, D. J. (2009) · Experimental & Molecular Medicine · doi:10.3858/emm.2009.41.8.091 · Cited by 78
Methods of induced pluripotent stem cells for clinical application
Seki, T., & Fukuda, K. (2015) · World Journal of Stem Cells · doi:10.4252/wjsc.v7.i1.116 · Cited by 78
Tan, Y., Ooi, S., & Wang, L. (2013) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x113086660068 · Cited by 78
MiR-25 Regulates Wwp2 and Fbxw7 and Promotes Reprogramming of Mouse Fibroblast Cells to iPSCs
Lu, D., Davis, M. P. A., Abreu‐Goodger, C., Wang, W., Campos, L. S., Siede, J., Vigorito, E., Skarnes, W. C., Dunham, I., Enright, A. J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040938 · Cited by 78
New strategies to generate induced pluripotent stem cells
O’Malley, A. J., Woltjen, K., & Kaji, K. (2009) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2009.09.005 · Cited by 78
Immunological aspects of RPE cell transplantation
Sugita, S., Mandai, M., Kamao, H., & Takahashi, M. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2021.100950 · Cited by 77
“Regarding insertional mutagenesis by retroviral vectors, the induction of human iPSC using non-integrative viral vectors such as adenovirus (Stadtfeld et al., 2008) or Sendai virus (Fusaki et al.”
Poleganov, M. A., Eminli, S., Beissert, T., Herz, S., Moon, J.-I., Goldmann, J., Beyer, A., Heck, R., Burkhart, I., Barea Roldan, D., et al. (2015) · Human Gene Therapy · doi:10.1089/hum.2015.045 · Cited by 77
Metadata
- Authors
- Stadtfeld, M., Nagaya, M., Utikal, J., Weir, G., & Hochedlinger, K.
- Affiliations
- Joslin Diabetes Center (US)
- Corresponding author
- Hochedlinger, Konrad
- Venue
- Science
- Published
- 2008-11-07
- Volume
- 322
- Issue
- 5903
- Pages
- 945-949
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC3987909
- OpenAlex
- W2050689355
- Cited by
- 1,683
- References
- 29
- Citations by year
- 2026: 12 · 2025: 13 · 2024: 33 · 2023: 22 · 2022: 32 · 2021: 55 · 2020: 50 · 2019: 38 · 2018: 63 · 2017: 63 · 2016: 104 · 2015: 105 · 2014: 139 · 2013: 161 · 2012: 185
- FWCI
- 82.28
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (1dp2od003266-01)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Animal Genetics and Reproduction
- Keywords
- induced pluripotent stem cells, Oct4, SOX2, KLF4, c-Myc, somatic cell reprogramming, DNA demethylation, teratoma, chimeric mice, fibroblasts, hepatocytes, insertional mutagenesis, patient-derived stem cells, embryonic stem cells
- MeSH terms
- Kruppel-Like Factor 4, Adenoviridae, Animals, Cell Differentiation, Cell Line, Chimera, Cloning, Molecular, Female, Fibroblasts, Genetic Vectors, Liver, Male, Teratoma, Genes, myc, Proto-Oncogene Proteins c-myc, Mice, SCID, Virus Integration, Transgenes, Hepatocytes, Pluripotent Stem Cells, Octamer Transcription Factor-3, Mice, Kruppel-Like Transcription Factors, SOXB1 Transcription Factors, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.